Program

1:05 pm 

Keynotes

The German were right; they are regulatory and functional autoantibodies- the story of silicone implants autoimmunity
Yehuda Shoenfeld, Israel

Anti-GPCR abs as biomarker and effector molecules
Gabriela Riemekasten, Germany

2:10 pm 

Systemic sclerosis

Role of ab and ab networks in SSc symptoms and co-morbidities
Susanne Schinke, Germany

Interaction of autoantibodies and microangiopathy in SSc patients
Jeska DeVries, Netherlands

Establishment of a novel humanized mouse model for SSc
Xinhua-Yu, China

3:25 pm

News from transplantation

New non-HLA antibodies in transplantation
Miroslaw Banasik, Poland

New insights into AT1R- and ETAR-antibody function
Aurelie Philippe, Germany

Antibody-mediated rejection after transplantation
Carmen Lefaucheur, France

Functionality of protease-activated receptor antibodies 
Rusan A. Catar, Germany

5:00 pm 

5:45 pm

1:00 pm

Role of anti-GPCR in cardiology

Novel concepts in the therapy of dilatative cardiomyopathy
Stephan Felix, Germany

The role of ß1 adrenergic receptor antibodies as biomarker in ACS
Diana Ernst, Germany

Stabilin as biomarker in the field of cardiology
Carsten Tschöpe, Germany

2:15 pm

Insight beyond anti-GPCR as biomarker I

What comes after ab binding? How to go beyond the cell surface?
Evi Kostenis, Germany

Pathogenetic role of autoantibodies against AT1R in mice
Frank Petersen, Germany

Secretome analysis – A way to look inside disease affected cells  
Cynthia Fehres, Germany

3:30 pm

Insight beyond anti-GPCR as biomarker II

Role of IL-13 in the development of occlusive vasculopathy in AT1R-induced mouse model for SSc
Xinhua-Yu, China

Thyrotropin receptor antibodies - blocked and stimulating
George Kahaly, Germany

4:10 pm